WebsiteClosers®, in partnership with Fortunet, presents a Medical Products Platform with $145M in LTM revenue, $22.3M in adjusted EBITDA (15.4% margin), and a 53% 4-year revenue CAGR. Established 2 decades ago, the Company operates two proprietary brands across medical consumables, adult care, and therapeutic home-care products, serving consumer, commercial, and institutional customers through established domestic and international channels.
Key Valuation Points
- 20+ Years in Business
- 12.7% TACOS | 26% Conversion Rate
- 170% Subscriber Growth (‘24 vs ‘25)
- 25% Projected YOY Profit Growth (’25 vs ’26)
- 4.5 Star (140k Reviews) Average Rating
- 270 SKUs
- 27% Repeat Customers
- 53% 4-Year CAGR
- Trademarked Brand with Patents
- $22.3M Adjusted EBITDA
- 71K+ Active Subscribers and growing
The portfolio includes approximately 270 active SKUs spanning medical examination gloves, adult wipes and underpads, therapeutic positioning pillows, and related healthcare products. Select medical devices have FDA 510(k) clearance; applicable products also hold Health Canada approvals and UK/EU certifications. The Company maintains trademark protections across 8 jurisdictions and 2 patents supporting its product portfolio.
Recurring purchasing is a core economic driver. More than 71,000 active Subscribers represent approximately 170% growth since 2024. In 2025, approximately 413,000 repeat customers generated 48.3% of revenue, without an active email, SMS, or loyalty marketing program. The platform served approximately 1.9 million customers in 2025.
Distribution spans Amazon, Walmart, wholesale, private label, and international marketplaces. More than 140,000 Amazon reviews averaging approximately 4.5 stars and #1 rankings in multiple categories support the Company's established market position.
The operating model is supported by 24 employees, 25+ suppliers across six countries, and fulfillment through Amazon FBA, Walmart Fulfillment Services, and three U.S. warehouse touchpoints. A diversified sourcing base, with a majority of production outside China, provides procurement flexibility and supports growth without a proportionate expansion of fixed infrastructure.
Scale Opportunities:
- Expand institutional medical supply distribution, national accounts, and government procurement.
- Launch 11+ products in current R&D across established and adjacent categories.
- Accelerate Walmart and international marketplace penetration.
- Develop direct-to-consumer distribution and CRM programs across the established customer base.
- Expand wholesale, private-label, and strategic distribution partnerships.
The acquisition offers strategic and financial sponsors a profitable Medical Products platform with established regulatory credentials, defensible marketplace positions, recurring demand, institutional channel exposure, and identifiable organic growth initiatives.
Contact WebsiteClosers® today to learn more about this exciting Medical Products Company.
WC 4148
